Syncom Formulations (India) Limited has informed regarding Disclosure of material issue
SYNCOMF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts more than Nifty Microcap 250 and 2.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Syncom Formulations (India) Limited has disclosed that its bid to acquire a material property from HDFC Bank Ltd. has been accepted. The company has successfully completed the purchase of the entire 7th Floor, Trade Star, located on Andheri-Kurla Road, Andheri (East), Mumbai, for a total consideration of Rs. 57.26 crore (Rupees Fifty-Seven Crore Twenty-Six Lakh). The disclosure was made under SEBI (LODR) Regulations, 2015, and the filing was signed off by CS Vaishali Agrawal, Company Secretary & Compliance Officer, dated 4th May 2026. This appears to be a commercial real estate acquisition funded entirely by HDFC Bank as the seller/financier.
The acquisition of a commercial property worth Rs. 57.26 crore represents a significant asset purchase but does not directly affect revenue or operational earnings. The cash outflow may impact near-term liquidity, while the long-term benefit depends on the company's use of the space for operations or leasing.